Literature DB >> 33510440

What's new in clinical CRISPR?

Carrie Arnold1.   

Abstract

Year:  2021        PMID： 33510440     DOI： 10.1038/s41591-020-01222-4

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

Review 1.  Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma.

Authors:  Huimin Kong; Enguo Ju; Ke Yi; Weiguo Xu; Yeh-Hsing Lao; Du Cheng; Qi Zhang; Yu Tao; Mingqiang Li; Jianxun Ding
Journal:  Adv Sci (Weinh)       Date:  2021-10-19       Impact factor: 16.806

Review 2.  Genetics Matters: Voyaging from the Past into the Future of Humanity and Sustainability.

Authors:  Acga Cheng; Jennifer Ann Harikrishna; Charles S Redwood; Lei Cheng Lit; Swapan K Nath; Kek Heng Chua
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 6.208

Review 3.  Thioredoxin-interacting protein in diabetic retinal neurodegeneration: A novel potential therapeutic target for diabetic retinopathy.

Authors:  Chengzhi Liu; Wenkang Dong; Zhengshuai Lv; Li Kong; Xiang Ren
Journal:  Front Neurosci       Date:  2022-08-09       Impact factor: 5.152

4.  In vivo processing of digital information molecularly with targeted specificity and robust reliability.

Authors:  Yangyi Liu; Yubin Ren; Jingjing Li; Fan Wang; Fei Wang; Chao Ma; Dong Chen; Xingyu Jiang; Chunhai Fan; Hongjie Zhang; Kai Liu
Journal:  Sci Adv       Date:  2022-08-05       Impact factor: 14.957
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.